The New England Journal of Medicine, 366, 20-33 Tricoci, P, Huang, Z, Held, C, Moliterno, D J, Armstrong, P W, Van de Werf, F, White, H D, Aylward, P E, Wallentin, L, Chen, E, Lokhnygina, Y, Pei, J, Leonardi, S, Rorick, T L, Kilian, A M, Jennings, L H K, Ambrosio, G, Bode, C, Cequier, A, Cornel, J H, Diaz, R, Erkan, A, Huber, K, Hudson, M P, Jiang, L, Jukema, J W, Lewis, B S, Lincoff, A M, Montalescot, G, Nicolau, J C, Ogawa, H, Pfisterer, M, Prieto, J C, Ruzyllo, W, Sinnaeve, P R, Storey, R F, Valgimigli, M, Whellan, D J, Widimsky, P, Strony, J, Harrington, R A, Mahaffey, K W, TRACER Investigators & Rasmussen, L H 2012, ' Thrombin-receptor antagonist vorapaxar in acute coronary syndromes ', The New England Journal of Medicine, vol. 366, no. 1, pp. 20-33 . https://doi.org/10.1056/NEJMoa1109719 Recercat. Dipósit de la Recerca de Catalunya instname Dipòsit Digital de la UB Universidad de Barcelona The New England Journal of Medicine, 366, 1, pp. 20-33